Medical Technology

@xconomy.com 3 years ago

Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally

@xconomy.com 4 years ago

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

@xconomy.com 4 years ago

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

@xconomy.com 4 years ago

Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More

@xconomy.com 5 years ago

Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More

@xconomy.com 5 years ago

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

@xconomy.com 5 years ago

RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures

@xconomy.com 5 years ago

Synthorx Files for IPO to Advance Enhanced Cytokine Drugs

@xconomy.com 6 years ago

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs